First-pass extracted concept

MRGPRX2

Candidate: concept label1 source documents4 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

Mas-related G protein-coupled receptor member X2

Extracted Explainers

What the tool is doing

The review centers on MRGPRX2 as a receptor associated with mast-cell activation and degranulation in response to diverse natural and pharmacologic ligands. It is framed as relevant to immunity, neural stimulus perception, and allergic or inflammatory disease.

Source 1DOIPubMed

What problem it solves

As a review topic, MRGPRX2 helps explain how chemically diverse secretagogues and neuropeptides can converge on mast-cell activation outside classical IgE pathways.

Source 1DOIPubMed

What it does not solve

The abstract does not establish a therapeutic intervention strategy, structural mechanism, or standardized engineering use case for MRGPRX2 itself.

Source 1DOIPubMed

Alternatives

The abstract contrasts MRGPRX2-linked responses with non-IgE-mediated immediate hypersensitivity as a disease mechanism, but does not lay out a detailed alternative receptor framework.

Source 1DOIPubMed

Evidence Snippets

Recent research on mast cell biology has turned its focus on MRGPRX2... a variety of both natural and pharmacologic ligands are being uncovered, linked to the ability to induce receptor-mediated MC activation and degranulation.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1disease association review summarysupports2021Source 1DOIPubMed

The review links MRGPRX2 to non-IgE-mediated immediate hypersensitivity drug reactions and suggests possible roles in asthma, atopic dermatitis, contact dermatitis, chronic spontaneous urticaria, and chronic inflammation.

Quoted textsource-backed
MRGPRX2 has been linked to the pathophysiology of non-IgE-mediated immediate hypersensitivity drug reactions. Different studies have shown its possible role in other allergic diseases as well, such as asthma, atopic dermatitis, contact dermatitis, and chronic spontaneous urticaria.
Claim 2review summarysupports2021Source 1DOIPubMed

Exogenous ligands discussed for MRGPRX2-family signaling include compound 48/80, mastoparan, quinolones, neuromuscular blocking agents, morphine, and vancomycin.

Quoted textsource-backed
Exogenous ligands include MC secretagogues such as compound 48/80 and mastoparan ... and several peptidergic drugs, among which are members of the quinolone family, neuromuscular blocking agents, morphine, and vancomycin.
Claim 3review summarysupports2021Source 1DOIPubMed

MRGPRX2 is described as a mast-cell-associated receptor with diverse natural and pharmacologic ligands that induce receptor-mediated mast-cell activation and degranulation.

Quoted textsource-backed
a variety of both natural and pharmacologic ligands are being uncovered, linked to the ability to induce receptor-mediated MC activation and degranulation
Claim 4review summarysupports2021Source 1DOIPubMed

Natural ligands discussed for MRGPRX2-family signaling include host defense peptides, basic molecules, substance P, vasointestinal peptide, and eosinophil granule-derived proteins.

Quoted textsource-backed
Natural ligands include host defense peptides, basic molecules, and key neuropeptides such as substance P and vasointestinal peptide ... as well as eosinophil granule-derived proteins.